DATA INSIGHTS

How does Pro Medicus perform after a contract win?

We take a closer look at all of Pro Medicus' contract wins since 2023 and how the stock performed on the day of the announcement.

Lead Writer
4 February 2025
This article is more than 12 months old and may be outdated
2 min read
How does Pro Medicus perform after a contract win?

Source: Shutterstock

Mentioned

Pro Medicus (ASX: PME) hit another fresh all-time high on Tuesday, up 4.7% and crossing $280 a share for the first time on record. The rally follows the announcement of a $53 million, seven-year contract with BayCare, a leading healthcare system in Florida.

One of Pro Medicus' key growth drivers is its ability to secure contracts across the US, Australia, and Europe. Since 2023, the company has announced 19 contracts, predominantly with US-based healthcare systems. Below, we're going to observe the key contract details as well as how the share price performed on the day of and day after the announcement.

Contract Wins Since 2023

Date
Contract
Min Value (A$m)
Term
16/01/2025
University of Kentucky
33
9
30/12/2024
Duke University Health
15
5
23/12/2024
Duly Health & Care
30
7
27/11/2024
Trinity Health
330
10
16/10/2024
NYU Langone
24
5
7/10/2024
HMED (Expansion 2)
32
5
28/05/2024
Mercy Health
98
8
28/05/2024
Consulting Radiology
9.5
5
28/05/2024
Nationwide Children's Hospital
11.5
7
28/05/2024
Nicklaus Children's Hospital
6.5
5
28/05/2024
Moffitt Cancer Center
9
8
13/11/2023
US Radiology Specialists
8.5
5
23/10/2023
Oregon Health & Science University
20
8
26/09/2023
South Shore
16
8
27/07/2023
Baylor Scott White
140
10
16/05/2023
Memorial Sloan Kettering
24
7
30/01/2023
Gundersen Health System
20
7
20/01/2023
Samaritan Health Services
12
8
Source: Pro Medicus

Key Insights

  • Largest contract was Trinity Health $330 million (27-Nov-24) for a yen-year contract

  • Average contract value of $46.6 million

  • Average contract term was seven years

Share Price Reaction

Next, we examine the key contract details alongside how the share price reacted on the announcement day and the following trading session.

Date
Contract
% Chg
Open to Close
Next Day
16/01/2025
University of Kentucky
-0.4%
-2.9%
-1.5%
30/12/2024
Duke University Health
0.0%
0.5%
-3.0%
23/12/2024
Duly Health & Care
2.7%
3.2%
-2.1%
28/11/2024
Trinity Health
8.7%
7.0%
1.5%
16/10/2024
NYU Langone
-2.4%
-3.1%
2.7%
7/10/2024
HMED (Expansion 2)
1.8%
1.7%
-1.6%
28/05/2024
Mercy Health
0.9%
-4.3%
1.4%
13/11/2023
US Radiology Specailists
0.1%
-1.2%
0.3%
23/10/2023
Oregon Health & Science University
1.5%
3.1%
-2.0%
26/09/2023
South Shore
12.4%
6.9%
0.8%
27/07/2023
Baylor Scott White
1.5%
0.3%
2.0%
16/05/2023
Memorial Sloan Kettering
-0.6%
-0.9%
-0.3%
30/01/2023
Gundersen Health System
1.2%
0.4%
1.5%
20/01/2023
Samaritan Health Services
1.8%
1.0%
1.8%
Source: Pro Medicus, Market Index | Trinity Health contract was announced after-hours on 27-Nov-24

Key Insights

On the day of the announcement, Pro Medicus shares:

  • Up an average 1.8%

  • Median gain of 0.9%

  • Positive 83.3% of the time

In terms of intraday price action (from open to close):

  • Down an average 0.3% (median also -0.3%)

  • Up just 50% of the time

This implies that the share price more or less settles lower than the open. While the share price might open higher, investors aren't that keen to bid the stock any higher.

The day after the announcement, the stock tends to:

  • Average gain of 0.4%

  • Median gain of 1.4%

  • Positive 66.7%

While Pro Medicus shares often open higher following contract announcements, the stock tends to settle lower by the close. This suggests some profit-taking or cautious investor sentiment. However, the positive trend on the following day implies that analyst upgrades and broker responses tend to provide further support, reinforcing confidence in the company's long-term growth trajectory.

ABOUT THE AUTHOR

Lead Writer

Kerry holds a Bachelor of Commerce from Monash University. He is passionate about equity research and trading (swing and intraday), with a focus on breaking down market-related catalysts into clear, contextual insights and developing data-driven market biases.

22/07/2026